INSERM are looking for a research officer for their St Etienne site to contribute to the development of research focused on digital health and vascular models, by combining basic research, translational research, and methodological innovation.
Zsuzsa Bagolyreceived her medical degree from the Faculty of Medicine at the University of Debrecen, Hungary, in 2004. She earned her PhD in clinical hemostasis in 2008 and qualified as specialist in laboratory medicine in 2011. She currently serves as Director of the Department of Laboratory Medicine and Vice-President for Diagnostic Affairs at the University of Debrecen,Clinical Center.
Her research spans both basic and clinical aspects of thrombosis and hemostasis, with particular emphasis on factor XIII, fibrinolysis, and cerebrovascular diseases, especially stroke.
She iscurrentlythe chair of the ISTHScientific and StandardizationSubcommittee on Factor XIII and Fibrinogen, and president of the Hungarian Society of Thrombosis and Haemostasis. She has been invited to speak at several meetings, including state-of-the-art lectures at ISTH, ISFP, IFRS congressesand plenary at ECTH. In recent years, she has received several prestigious scientific awards, among them the L’Oréal–UNESCO Prize for Women in Science.
Professor BethPsaila
Professor BethPsailais a Professor of Haematology at the University of Oxford, and a Group Leader at the Weatherall Institute of Molecular Medicine and the Ludwig Institute for Cancer Research. She leads a research group focused on myeloproliferative neoplasms (MPNs) and megakaryocyte/platelet biology, and in her clinical practice focuses on the care of MPNs, including leading a portfolio of Phase 1 – 3 clinical trials.
Professor Cheng-Hock Toh, CBE, is Professor of Medical Haematology at the University of Liverpool. His career has been defined by a commitment to advancing haematology through clinical excellence, inclusive leadership, creative mentoring and innovative research. He has served as the first haematologist to be Academic Vice President of the Royal College of Physicians and is the first President of the British Society for Haematology from an ethnic minority background.
His translational research addresses areas of genuine unmet need, focusing on acute critical illness rather than refining established models. By continuously evolving to remain relevant, his work has influenced thinking beyond haematology, reshaping perspectives across multiple medical specialties.
At the BSHT meeting, Professor Toh will highlight a pioneering concept: a convergent model of coagulation that integrates inflammation and innate immune activation. Building on the traditional waterfall cascade and cell-based models of coagulation, this framework offers a unified understanding of haemostasis and thrombosis in health and disease.
Dr Jamie O’Sullivan is a principal investigator and assistant professor at the Royal College of Surgeons in Ireland (RCSI). She completed her PhD in Trinity College Dublin focused on the structure function of von Willebrand Factor (VWF). Her research on VWF was recognised internationally with the Martin Villar Haemostasis Award. Following her PhD, Dr O’Sullivan pursued postdoctoral training, including a period at KU Leuven, where she investigated the biology of VWF multimers using innovative microfluidic systems to model vascular blood flow. Jamie was appointed as a lecturer in vascular biology at RCSI in September 2019 where she leads a growing research group investigating the bidirectional crosstalk between coagulation and cancer and the role of the vasculature in metastasis. Her group is funded through a number of prestigious research grants including SFI Frontiers for the Future Programme and Irish Research Council Laureate Award as well as partnerships with industry collaborators. To date she has published more than 70 peer review papers and also serves as the current chair of the International Society for Thrombosis and Haemostasis SSC committee for VWF.
Dr. Craig Jenne, PhD,is a Professor within the Department of Microbiology, Immunology and Infectious Diseases, the Department of Critical Care Medicine at the University of Calgary and holds an adjunct appointment within the Faculty of Veterinary Medicine. Dr. Jenne is the Jessie Boden Lloyd Professor in Immunology Research and is the Deputy Director of the Snyder Institute for Chronic Disease. Dr. Jenne’s research program has published more than 100 journal articles, receiving more than 13000 citations, an h-index of 55 and an i10-index of 92.
Dr. Jenne research program blends intravital microscopy to study the early innate immune response to infection and whole organ proteomics to understand the
#J-18808-Ljbffr
